Treatment patterns and glycated haemoglobin levels over 36 months in individuals with type 2 diabetes initiating second‐line glucose‐lowering therapy: The global DISCOVER study

AIMS: To describe glucose‐lowering treatment regimens and glycated haemoglobin (HbA1c) trajectories in individuals with type 2 diabetes (T2D) over 36 months of follow‐up from the start of second‐line therapy. MATERIALS AND METHODS: This data analysis from the 3‐year, observational DISCOVER study pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Charbonnel, Bernard H., Chen, Hungta, Cid‐Ruzafa, Javier, Cooper, Andrew, Fenici, Peter, Gomes, Marilia B., Saraiva, Gabriela L., Medina, Jesús, Nicolucci, Antonio, Shestakova, Marina V., Shimomura, Iichiro, Surmont, Filip, Tang, Fengming, Vora, Jiten, Watada, Hirotaka, Khunti, Kamlesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087302/
https://www.ncbi.nlm.nih.gov/pubmed/36111434
http://dx.doi.org/10.1111/dom.14842

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087302/
https://www.ncbi.nlm.nih.gov/pubmed/36111434
http://dx.doi.org/10.1111/dom.14842

Ejemplares similares